FR2398051B1 - - Google Patents

Info

Publication number
FR2398051B1
FR2398051B1 FR7821686A FR7821686A FR2398051B1 FR 2398051 B1 FR2398051 B1 FR 2398051B1 FR 7821686 A FR7821686 A FR 7821686A FR 7821686 A FR7821686 A FR 7821686A FR 2398051 B1 FR2398051 B1 FR 2398051B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7821686A
Other languages
French (fr)
Other versions
FR2398051A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP8855677A external-priority patent/JPS5424868A/ja
Priority claimed from JP11424277A external-priority patent/JPS5446776A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2398051A1 publication Critical patent/FR2398051A1/fr
Application granted granted Critical
Publication of FR2398051B1 publication Critical patent/FR2398051B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR7821686A 1977-07-22 1978-07-21 Nouveau fragment du glucagon et ses derives Granted FR2398051A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8855677A JPS5424868A (en) 1977-07-22 1977-07-22 Novel glucagon fragment
JP11424277A JPS5446776A (en) 1977-09-21 1977-09-21 Novel peptide

Publications (2)

Publication Number Publication Date
FR2398051A1 FR2398051A1 (fr) 1979-02-16
FR2398051B1 true FR2398051B1 (ref) 1983-09-16

Family

ID=26429925

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7821686A Granted FR2398051A1 (fr) 1977-07-22 1978-07-21 Nouveau fragment du glucagon et ses derives

Country Status (4)

Country Link
US (1) US4206199A (ref)
DE (2) DE2858718C2 (ref)
FR (1) FR2398051A1 (ref)
GB (1) GB2002387B (ref)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5539702A (en) * 1978-08-30 1980-03-19 Takeda Chem Ind Ltd Method of measuring enzyme immunity of pancreas glucagon
JPS5657753A (en) * 1979-10-16 1981-05-20 Toyo Jozo Co Ltd Novel glucagon fragment, and its use
JPS56163456A (en) * 1980-05-21 1981-12-16 Otsuka Pharmaceut Co Ltd Preparation of antigen
US4423034A (en) * 1980-10-16 1983-12-27 Toyo Jozo Kabushiki Kaisha Process for the preparation of antibodies
US5693741A (en) 1988-03-15 1997-12-02 The Boeing Company Liquid molding compounds
US4430326A (en) 1981-12-22 1984-02-07 University Patents, Inc. Method of diminishing glucose levels resulting from endogenous glucagon
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
FR2602679B1 (fr) * 1986-08-14 1989-02-24 Inst Nat Sante Rech Med Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US7601691B2 (en) 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
PT1180121E (pt) * 1999-05-17 2004-03-31 Conjuchem Inc Peptidos insulinotropicos de longa duracao
US20040266673A1 (en) * 2002-07-31 2004-12-30 Peter Bakis Long lasting natriuretic peptide derivatives
US6887470B1 (en) 1999-09-10 2005-05-03 Conjuchem, Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
JP3974619B2 (ja) * 2003-01-10 2007-09-12 株式会社新潟ティーエルオー 遺伝子治療用ベクター及び該遺伝子治療用ベクターを投与された哺乳動物中又は培養細胞中の目的タンパク質の定量方法
CA2564031A1 (en) * 2004-04-23 2005-11-03 Conjuchem Biotechnologies Inc. Method for the purification of albumin conjugates
US8039432B2 (en) * 2005-11-09 2011-10-18 Conjuchem, Llc Method of treatment of diabetes and/or obesity with reduced nausea side effect
CN101384623B (zh) * 2005-12-22 2013-07-24 常山凯捷健生物药物研发（河北）有限公司 白蛋白与治疗剂的预成型偶联物的制备方法
US20090099074A1 (en) * 2007-01-10 2009-04-16 Conjuchem Biotechnologies Inc. Modulating food intake
BR112017005110A2 (pt) 2014-09-16 2018-01-23 Regeneron Pharma anticorpo monoclonal isolado ou fragmento de ligação ao antígeno do mesmo, molécula isolada de ácido nucleico, composição farmacêutica, e, método para diminuir níveis de glicose no sangue ou para tratar uma condição ou doença.
CA3034777A1 (en) 2016-08-30 2018-03-08 Regeneron Pharmaceuticals, Inc. Methods of treating severe insulin resistance by interfering with glucagon receptor signaling
US20190248888A1 (en) 2016-10-20 2019-08-15 Regeneron Pharmaceuticals, Inc. Methods of lowering blood glucose levels
MX2020002057A (es) 2017-08-22 2020-07-13 Regeneron Pharma Metodos para tratar trastornos del ciclo de la urea mediante interferencia con la señalizacion del receptor del glucagon.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1584386A (ref) * 1967-08-19 1969-12-19
DE1643345C3 (de) * 1967-08-19 1975-09-25 Hoechst Ag, 6000 Frankfurt Glucagonderivat und Verfahren zur Herstellung von Glucagon
US3979506A (en) * 1974-10-11 1976-09-07 Pierce Chemical Company Radioactive compounds for labeling proteins

Also Published As

Publication number Publication date
DE2832090A1 (de) 1979-02-08
US4206199A (en) 1980-06-03
GB2002387B (en) 1982-02-10
DE2858718C2 (ref) 1989-07-06
GB2002387A (en) 1979-02-21
FR2398051A1 (fr) 1979-02-16
DE2832090C2 (ref) 1989-07-20

Similar Documents

Publication Publication Date Title
FR2377630B1 (ref)
FR2377376B1 (ref)
FR2377589B1 (ref)
FR2376420B1 (ref)
FR2398051B1 (ref)
FR2377460B1 (ref)
FR2378221B1 (ref)
FR2378152B1 (ref)
AU3353778A (ref)
DK139563C (ref)
AU495917B2 (ref)
AR210643A1 (ref)
AU71461S (ref)
BG26040A1 (ref)
BE873002A (ref)
BE868323A (ref)
BE870787A (ref)
BE871419A (ref)
BG25828A1 (ref)
BE865722A (ref)
BE851449A (ref)
BE871991A (ref)
CH607419A5 (ref)
CH601074A5 (ref)
BE872973A (ref)

Legal Events

Date Code Title Description
ST Notification of lapse